Study of Mepolizumab-based Regimen Compared to Conventional Therapeutic Strategy in Patients With Eosinophilic Granulomatosis With Polyangiitis (E-merge)
Clinical trial NCT05030155 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05030155
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-30
- Primary completion
- 2025-11-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.